InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
29%
T+90 mean return
-19.7%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Shepard Jay, Director. Insider active across 5 companies, notably INOVIO PHARMACEUTICALS, INC.. In total, 20 disclosures have been published. Activity tracked since 27 May 2021. The latest transaction was disclosed on 28 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations20 total
79,873 shares0Common StockSEC:0001628280-26-039526:0
2,167 sharesCommon StockSEC:0001055726-25-000038:0
24,311 shares0Class A Common StockSEC:0000950170-24-076213:0
23,000 shares0Common StockSEC:0001628280-24-025210:0
2,166 sharesCommon StockSEC:0001055726-24-000032:0
22,350 shares0Class A Common StockSEC:0001209191-23-039143:0
5,150 shares0Common StockSEC:0001628280-23-022453:0
19,000 sharesCommon StockSEC:0001055726-23-000036:0
4,273 sharesCommon StockSEC:0001055726-23-000001:0
21,571 shares0Class A Common StockSEC:0001209191-22-033982:0
18,000 sharesCommon StockSEC:0001055726-22-000040:0
4,274 sharesCommon StockSEC:0001055726-22-000002
4,274 sharesCommon StockSEC:0001055726-22-000002:0
22,766 shares0Class A Common StockSEC:0001209191-21-038223:0
22,766 shares0Class A Common StockSEC:0001209191-21-038223
12,376 shares0Common StockSEC:0001628280-21-011359:0
12,376 shares0Common StockSEC:0001628280-21-011359
8,700 sharesCommon StockSEC:0001055726-21-000046
8,700 sharesCommon StockSEC:0001055726-21-000046:0
64,800 sharesCommon StockSEC:0001209191-16-094552:0
20 of 20 declarations
About Shepard Jay
Jay Shepard serves as a Board Member at Inovio Pharmaceuticals, Inc. and Esperion Therapeutics, Inc. In this role, he oversees operations and participates in strategic decision-making. His expertise in the biopharmaceutical sector allows him to provide significant contributions to the board.
